Valeant Pharmaceuticals International Inc (NYSE:VRX)

237.53
Delayed Data
As of May 22
 +4.26 / +1.83%
Today’s Change
106.00
Today|||52-Week Range
238.49
+65.98%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues2.5B3.5B5.8B8.3B
 
 
 
 
 
Cost of Goods Sold672.0M981.2M1.8B2.1B
 
 
 
 
 
Depreciation And Amortization612.6M986.2M1.4B1.7B
 
 
 
 
 
 
Operating ExpensesGross Income1.2B1.6B2.6B4.5B
 
 
 
 
 
General Expenses638.2M835.1M1.5B2.3B
 
 
 
 
 
Other Operating Expenses0.000.00174.2M0.00
 
 
Research And Development65.7M79.1M156.8M246.0M
 
 
 
 
 
Total Operating Expenses1.9B2.8B4.8B6.0B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income540.6M744.1M979.6M2.3B
 
 
 
 
 
Extraordinary Credit11.0M5.3M--64.1M
 
 
 
 
Extraordinary Charge-290.0M-689.8M-1.4B-725.0M
 
 
 
 
 
Interest Expense On Debt333.0M481.6M844.3M971.0M
 
 
 
 
 
Other Expenses49.3M21.8M-13.8M446.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.0M-394.2M-1.3B1.1B
 
 
 
 
 
Income Taxes-177.6M-278.2M-450.8M-180.4M
 
 
 
 
 
Minority Interest0.000.00-2.5M-1.3M
 
 
 
Net Income159.6M-116.0M-866.1M913.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS304.7M305.4M321.0M335.4M
 
 
 
 
 
Shares To Calculate EPS Diluted326.1M305.4M327.5M341.5M
 
 
 
 
 
 
Earnings Per ShareEPS$0.52-$0.38-$2.70$2.72
 
 
 
 
 
EPS Diluted$0.49-$0.38-$2.70$2.67
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account